CLBS12-P01
Not Applicable
Completed
- Conditions
- Patients with critical limb ischemia (CLI) due to arteriosclerosis obliterans (ASO) and patients with CLI due to Buerger's Disease (BD)
- Registration Number
- JPRN-jRCT1080223694
- Lead Sponsor
- EPS Corporation (Global Sponsor: Caladrius Biosciences, Inc.)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Subject has CLI caused by ASO or BD
Exclusion Criteria
< 20 years old
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method